Tags for This Article:

Canada (741)  OpEdNews (534)  Australia (370)  Press Release (260)  Health Care Costs (234)  Dept Of Justice DoJ Crimes (218)  Drug Companies- Marketing (203)  FDA (162)  FDA (155)  New Zealand (137)  Drugs Prescription (128)  US Midwest (110)  Health Care Liability (106)  US Northeast (98)  US South (86)  US Southeast (85)  US Northwest (80) 

Populum Tag Cloud
       Control Panel
Fine tune your search to access content
Articles
Diaries Products
Events All
All time
Last 6 mos
Last month
Last week
Last 24 hrs
From:
Month  Day   Year

To:
Month  Day   Year
Alphabet
Popularity
Count ON
Count OFF
This Level
Sub-levels

 

 

 

Tag(s): ; ; ; ; ; ; ; ; ; ; (more...) ; ; ; ; ; ;  (less...)
Add to My Group
January 25, 2007 at 13:35:28

Eli Lilly The Habitual Offender

by Evelyn Pringle     Page 2 of 3 page(s)

www.opednews.com

 
Tell A Friend

View Ratings | Rate It  

"So, if we get 39,000 adverse event reports about Prozac, the number of people who have actually suffered such problems is estimated to be 100 times as many, or roughly four million people," investigative journalist Robert Whitaker explained in an interview for Street Spirit in August 2005.

"This makes Prozac," he said, "the most complained about drug in America, by far."



"There were more adverse event reports received about Prozac in its first two years on the market than had been reported on the leading tricyclic antidepressant in 20 years," he added.

On December 18, 2003, Lilly sent letters to healthcare professionals in the UK, saying that Prozac was not recommended for children for any use, but issued no warning to doctors in the US.

In a situation similar to the Zyprexa document case, a couple years ago, the British Medical Journal received a series of internal Lilly documents and studies on Prozac from an anonymous source. The BMJ sent the documents to authorities, including US Congressman Maurice Hinchey and the FDA.

Congressman Hinchey sent the materials to psychiatrist, Dr Peter Breggin, author of Talking Back to Prozac, and The Anti-Depressant Fact Book, who reviewed the documents and issued a January 12, 2005 report.

After examining the documents, Dr Breggin confirmed their authenticity as those that he had evaluated in the early 1990s when he served as an expert for the combined Multi-District Litigation concerning Prozac. He in fact testified about the documents during a trial in 1994 after which, he says, they seemed to just disappear.

One group of documents he examined, contained a study by the FDA on the increased post marketing reports of "hostility" and "intentional injury" by patients on Prozac. For this study, the FDA compared patients using the antidepressant, trazodone, with Prozac patients, and found a 24-fold relative increase of reports of hostility and intentional injury per prescription of Prozac compared to trazodone.

The documents Dr Breggin reviewed also contained graphs showing a 40-fold relative increase in reports of suicide attempts, overdose, and psychotic depression in patients on Prozac compared to patients on trazodone.

An August 6, 1989, Lilly document says that doctors should be warned that Prozac patients were at a higher risk of suicide unless they receive a sedative, stating: "The counterindication because of acute suicidality should become a warning whereby the physicians should be advised that in the absence of sedation, the risk of higher suicidality should be taken into account."

A June 13, 1990, letter to Lilly from a concerned doctor states: "There appears to be growing concern that Prozac may somehow trigger a suicidal preoccupation in a small subset of patients and that their families should be warned of this potential risk. It is certainly possible that some of the cases reported are "coincidence" in that the depressed person may have attempted suicide independently of Prozac. However, some of these cases appear to be in patients taking Prozac for reasons other than depression."

Yet two months later, on August 31, 1990, Lilly sent out a Dear Doctor letter assuring health care professionals that there is no "causal relationship between Prozac and suicidality (ideation or acts)."

The hidden Prozac documents have come back to haunt Lilly. On January 14, 2005, a class action lawsuit was filed in Canada with claims that Lilly withheld information on the safety of Prozac. The plaintiffs contend that the reason Lilly failed to disclose the documents was because they showed a drastic increases in suicide attempts and other violent acts in patient using Prozac when compared to four other drugs.

Throughout the 1990s, while swearing publicly that Prozac did not increase the risk of suicide or violence, Lilly quietly settled lawsuits out of court and was able to keep the incriminating evidence hidden by obtaining court orders to seal the documents, just as it had been doing with Zyprexa until the latest batch of documents was leaked to the press.

Since the FDA was placed on permanent vacation when George W Bush took up residence in the White House, these days litigation appears to be about the only means available for unearthing hidden studies that show a drug's adverse effects.

In the case of Zyprexa, Lilly has so far settled with an estimated 26,000 plaintiffs, at a cost of over $1 billion. The incriminating documents leaked to the press last month, came to light during litigation with these plaintiffs but even after the litigation was settled, they were kept under seal with a court order.

 1  |  2  |  3

 

Evelyn Pringle is a columnist for OpEd News and investigative journalist focused on exposing corruption in government and corporate America.

Contact Author
Contact Editor
View Other Articles by Author

 

Bookmark this page: (what's this?)

NETSCAPE      DIGG THIS      Add This Page to Mr Wong!           NEWSVINE      DEl.ICIO.US      Looksmart Furl      My Web      Tag!RawSugar      Blink List     (More...)
Comments: Expand   Shrink   Hide  
1 comments

Danny Haszard Bangor Maine Counter-cult educator
Danny HaszardDanny Haszard Bangor Maine Counter-cult educator

Zyprexa LIES

Eli Lilly Zyprexa scandal

Zyprexa off label promotion scandal is all over the news now.
Lilly drug reps are alleged to have called their marketing ploy,"Viva zyprexa".

Eli Lilly zyprexa cost me over $250.00 a month supply out of my own pocket X 4 years and has up to ten times the risk (over non users) of causing diabetes and severe weight gain.

Zyprexa which is only FDA approved for schizophrenia (.5-1% of pop) and some bipolar (2% pop) and then an even smaller percentage of theses two groups.
So how does Zyprexa get to be the 7th largest drug sale in the world?
Eli Lilly is in deep trouble for using their drug reps to 'encourage' doctors to write zyprexa for non-FDA approved 'off label' uses.

The drug causes increased diabetes risk,and medicare picks up all the expensive fallout.There are now 7 states (and counting) going after Lilly for fraud and restitution.


---
Daniel Haszard www.zyprexa-victims.com

by Danny Haszard (2 articles, 0 quicklinks, 0 diaries, 52 comments) on Thursday, January 25, 2007 at 2:12:52 PM
 

 

1 comments

 

Tell A Friend

 


Copyright © OpEdNews, 2002-2008

Blog Ads

 

 

 

 

Most Popular Articles
in the Last 2 Days
(by Recommend Emails)

What I Learned At The Sarah Palin Rally Before They Threw Me Out! by Linda Milazzo

30 Lies Refuted about Ayers and Obama Posted by John Wilson

Representatives Were Threatened with "Martial Law" if Bailout Bill Did Not Pass by Patrick Henningsen

This Is Our Obama! Posted by Donna Roepenack

Those Who Call Obama A Muslim Posted by Rob Kall

This is Your Nation on White Privilege Posted by Siv O'Neall

The End of American Hegemony by Paul Craig Roberts

Meet The $700 Billion Bailout Czar by Rob Kall

Martial Law? by Jayne Lyn Stahl

I Just Prevented Thousands of Californians from Having to Vote on Provisional Ballots! by Emily Levy

Go To Top 50 Most Popular